CRESEMBA™ now available in Canada for the treatment of invasive aspergillosis and invasive mucormycosis

BLAINVILLE, QC, May 2, 2019 /CNW Telbec/ - AVIR Pharma Inc. (AVIR), is pleased to announce that Cresemba™ (isavuconazole, as isavuconazonium sulfate), an antifungal approved for the treatment of adult patients with invasive aspergillosis or with invasive mucormycosis, is now available in Canada.1 Invasive aspergillosis and invasive mucormycosis are life-threatening fungal infections often occurring in patients with solid organ transplants, cancer and other immunocompromised patients.

"We are extremely proud to announce the availability of Cresemba and offer Canadian patients and healthcare professionals an important new therapeutic option for the treatment of invasive aspergillosis and invasive murcormycosis. Cresemba is a great addition to AVIR's anti-infective portfolio of products and will provide potential commercial synergy with Zevtera® (ceftobiprole medocaril)." said Olivier St-Denis, President, AVIR Pharma.

In June 2017 AVIR Pharma Inc. and Basilea Pharmaceutica Ltd entered into a distribution and license agreement for CresembaTM and Zevtera® in Canada.   Cresemba is the only azole antifungal currently indicated for the treatment of both invasive aspergillosis and invasive mucormycosis.

"As a front-line Infectious Disease Physician, I see a great need for novel compounds that demonstrate both efficacy and tolerability to treat invasive fungal infections. Isavuconazole with expanded coverage that includes both Aspergillus spp and Mucorales spp, will be an important addition to the existing treatment options for managing Invasive Fungal Infections." said Dr. Shariq Haider (Juravinski Cancer Centre - Hamilton Health Sciences)

About CRESEMBA (isavuconazole)

Isavuconazole is an intravenous (i.v.) and oral azole antifungal and the active agent of the prodrug isavuconazonium sulfate. It is approved in Canada and in the United States 2 for patients 18 years of age and older in the treatment of invasive aspergillosis and invasive mucormycosis. In Europe, isavuconazole received marketing authorization for the treatment of adult patients with invasive aspergillosis and for the treatment of adult patients with mucormycosis for whom amphotericin B is inappropriate.3 Isavuconazole has orphan drug designation for the approved indications in Europe and the US.

Health Canada's approval of Cresemba was based on data from two Phase 3 clinical trials in adult patients with invasive fungal infections: SECURE, a randomized, double-blind, non-inferiority (versus active-control voriconazole) study of 516 adult patients with invasive aspergillosis; and VITAL, an open-label non-comparative study of Cresemba™ which included a subpopulation of 37 patients with invasive mucormycosis. In both studies, the primary endpoint was all-cause mortality at day 42.  

About invasive aspergillosis and invasive mucormycosis

Invasive aspergillosis and invasive mucormycosis are life-threatening fungal infections that often affect immunocompromised patients, such as patients with cancer. Invasive aspergillosis is known for high morbidity and mortality. Invasive mucormycosis is a rapidly progressing and life-threatening invasive fungal infection, known for high morbidity and mortality.

About AVIR Pharma Inc.

AVIR Pharma Inc. is a wholly-owned, privately-held Canadian pharmaceutical company whose mission is to enhance the lives of Canadians through the acquisition, in-licensing and co-development of innovative, specialty pharmaceutical products. Located in Blainville, Quebec, AVIR Pharma Inc. is an affiliate of the Laboratoire Riva Group, an established company with over 40 years of experience in manufacturing, distributing and promoting pharmaceutical products in the Canadian marketplace. For more information, please visit the company's web site at www.avirpharma.com.

About Basilea Pharmaceutica Ltd.

Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company, focused on the development of products that address the medical challenges in the therapeutic areas of oncology and anti-infectives. With two commercialized drugs, the company is committed to discovering, developing and commercializing innovative pharmaceutical products to meet the medical needs of patients with serious and life-threatening conditions. Basilea Pharmaceutica Ltd. is headquartered in Basel, Switzerland and listed on the SIX Swiss Exchange (SIX: BSLN). Additional information can be found at Basilea's website www.basilea.com.

_________________________________________________________
1CRESEMBA™ (isavuconazole) Product Monograph : AVIR Pharma Inc.; December 24, 2018 (http://avirpharma.com/pdf/Product-Monograph-Cresemba.pdf )
2Cresemba® US prescribing information [Accessed: December 6, 2018] https://www.astellas.us/docs/cresemba.pdf
3European Public Assessment Report (EPAR) Cresemba®: http://www.ema.europa.eu [Accessed:  April 30, 2019]

SOURCE Avir Pharma

#BIOHACKING: LATEST TREND IN HEALTH & WELLNESS

Neuroscience Expert Shares How Biohacking Will Change the Wellness IndustryIf you haven't heard of "biohacking" yet, you will soon. It brings the concept of mindfulness to the next level and its development has been rapid and recent. Biohacking combines science, biology, and self-experimentation to optimize health, well-being, and focus. Simply put, it's a DIY approach to wellness that refers to a wide range of activities including meditation, yoga, cleanse diets, and more. Once considered new-age and radical, these practices have risen in popularity. With more research and investment dollars being spewed into the industry, this health trend is dominating the wellness space and is on the verge of changing the industry. At the forefront of the biohacking community is neuroscience expert Dr. Patrick Porter.  "Biohacking has hit the mainstream and whether you believe in these practices or not, they will undoubtedly impact the health industry..." ...says Dr. Porter, who presented research along with Ariana Huffington and other notable biohackers last month at the National Biohacking Conference in Los Angeles. Biohacking has made tremendous advances in treating conditions like mental health and addiction. Although in the past, biohacking has received criticism for being unregulated, biohackers argue that's exactly why it needs to be studied and have close attention by the public. "It's all about open access to science and what works for you. When it comes to health, you are your own best advocate. No one can watch over you better than yourself," says Porter.  Porter's contribution to biohacking involves research on brainwaves and technology. A pioneer in this area, Porter has emerged as a leader in the digital health and wellness field. He is the creator of the BrainTap Pro mobile app, a mind-development tool designed to help users de-stress while achieving physical, mental, and emotional balance. Using frequency-following technology as well as guided visualization, the app gives anyone the ability to achieve the mental state they want in mere minutes (unlike traditional meditation which can take years to master.) While other apps only focus on one brainwave (such as alpha waves that calm and soothe) BrainTap is based on the understanding that no complex human task has only one brainwave state but rather a symphony of waves working together.  "You can actually trigger neurotransmitter production through brainwave entrainment and this is a game changer for mental and physical health," says Dr. Porter.  Dr. Porter has been instrumental in the nationwide movement to optimize healthcare through biohacking. He is sharing information with the public on what mainstream biohacking means for the wellness industry. IN AN INTERVIEW / ARTICLE, DR. PORTER CAN DISCUSS:Facts and myths about biohackingBiohacking - the latest trend in health and wellnessHow to trigger neurotransmitter production through brainwave entrainmentHow to biohack your brain with light, sound, and vibrationWhat mainstream biohacking means for the healthcare industry  ABOUT DR. PATRICK PORTER:
Dr. Patrick K. Porter, Ph.D., is an award-winning author, entrepreneur, and speaker. He is the creator of BrainTap Technology™ a company that produces digital tools for health and wellness. BrainTap’s mind development apps and accessories use Creative Visualization and Relaxation to help people overcome stress and insomnia, lose weight, stop smoking, manage pain, accelerate learning, and much more. BrainTap Tech has produced over 800 custom sessions and has sold more than 3-million books and recordings worldwide. With stress-related health and lifestyle issues at an all-time high, BrainTap has emerged as a leader in the digital health and wellness field.  For more information visit:https://braintaptech.com/

Canada's Newly Certified Medical Specialists Struggle to Find Work

OTTAWA, May 1, 2019 /CNW/ - A study based on a multi-year survey of 6,200 specialists released today by the Royal College of Physicians and Surgeons of Canada revealed the highest percentage of reported employment challenges since the launch of the Royal College Employment Survey in 2011. Nineteen percent of newly certified medical and surgical specialists were not able to find work immediately in their specialty following completion of their training in 2017.  

"Difficulties in placing newly graduated specialists into full-time jobs are a great loss for both patients and the specialists," says Dr. Andrew Padmos, chief executive officer at the Royal College.

When asked to identify what they perceived to be the barriers to their immediate employment, survey respondents noted

  • The scarcity of positions in their particular specialty in Canada 
  • Limited information on job opportunities 
  • Family obligations 
  • Lack of available health care resources (e.g. operating-room time, hospital beds) 
  • The delayed retirement of senior physicians and surgeons 

Since the Royal College began gathering this data in 2011, between 14% and 19% of new specialists have reported problems finding employment right after they have been certified. 

The good news is that 61% of new specialists who reported employment challenges at the time of certification had secured a clinical position by the time they received the Follow-Up Survey (12-17 months post-certification). 

"It would be easy to jump to the conclusion that Canada has an oversupply of specialists," says Danielle Fréchette, executive director of the Royal College's Office of Research, Health Policy and Advocacy. "We have more research to do, but there are a number of factors that seem to be contributing to this worrisome trend." Fréchette suggests that solutions lie in better alignment in the planning of  workforce requirements and health care needs, and ensuring that information is more readily shared about available job opportunities. 

Fréchette is one of several authors who analyzed years of data (2011-2017) and produced the report Employment Patterns of Canada's Newly Certified Medical Specialists: Findings from the Royal College Employment Studythat was released today.

The report also revealed that year over year, between 42% and 51% of survey respondents are continuing with further training after completing their certification exam. While this is a popular and immediate option for a high proportion of respondents, many also report they are pursuing even more specialized training to enhance their long-term employment prospects. 

Survey data from 2017 continues to show that employment challenges are most pronounced in surgical and more resource-intensive specialties. Specialists in Neurosurgery and Radiation Oncology have been hardest hit over the last seven years of data collection, followed closely by those in Orthopedic Surgery and Nuclear Medicine. 

Workforce planning by provincial-territorial governments is currently focused mostly on aligning physician supply with the health care needs of society. "While this is critical, it is also equally important to consider the availability of practice resources, such as operating room time, staff and beds, when addressing issues related to access to employment," says Fréchette.

The full report and a media backgrounder are available at www.royalcollege.ca/rcsite/health-policy/employment-study-e.

The Royal College of Physicians and Surgeons of Canada is the national professional association that oversees the medical education of specialists in Canada. We accredit the university programs that train resident physicians for their specialty practices, and we administer the examinations that residents must pass to become certified as specialists. In collaboration with health organizations and government agencies, the Royal College also plays a role in developing sound health policy in Canada.

www.royalcollege.ca

SOURCE Royal College of Physicians and Surgeons of Canada

Three Mefloquine lawsuits filed against Government of Canada

TORONTO, May 1, 2019 /CNW/ - Three separate lawsuits have been filed in the Federal Court by a total of 8 individuals against the Government of Canada alleging that the Government, through the Department of National Defence, ordered members of the Canadian Armed Forces to take an anti-malarial medication known as "Mefloquine" without adequately informing CAF Members of the severe adverse reactions, despite warnings from the drug manufacturer. The lawsuits allege that the wrongdoing occurred from 1990-2017. These are three of several lawsuits being brought by thousands of current and former CAF Members against the Government of Canada for the suffering (or injuries or harm) that ensued from being forced to take Mefloquine.  

Mefloquine is known to cause serious side effects that can persist for months or years and can become permanent. Serious symptoms include: 

  • anxiety 
  • unreasonable feeling that people are trying to harm you, do not like you, etc. (Paranoia) 
  • depression 
  • seeing or hearing things that are not there (hallucinations) 
  • thought of suicide or harming yourself 
  • feeling restless 
  • feeling confused 
  • unusual behavior 

Mefloquine can cause serious nervous-system problems in some people. Symptoms of serious nervous system problems include: 

  • dizziness 
  • a feeling that you or things around you are moving or spinning (vertigo) 
  • loss of balance 
  • ringing sound in your ears (tinnitus) 
  • convulsions (seizures) in people who already have seizures (epilepsy) 
  • unable to sleep (insomnia) 

Howie, Sacks & Henry LLP and Waddell Phillips Professional Corporation are the lawyers for the Plaintiffs and can be reached at the addresses below for further information regarding the lawsuits. 

About Howie, Sacks & Henry LLP

Howie, Sacks & Henry advances mass tort claims and class actions on behalf of people injured by dangerous products, pharmaceuticals and medical devices. These include victims who have suffered exposure to asbestos, cancer caused by the use of baby powder, the side effects of pharmaceutical drugs, and those adversely impacted by defective medical devices, including St. Jude Defibrillators, Hernia Mesh and Transvaginal Mesh.

For more information on the Mefloquine Lawsuits, please visit: https://www.hshlawyers.com/expertise/mass-tort-class-action-litigation/mefloquine/, or call Paul Miller at 416-361-5990.

About Waddell Phillips PC

Waddell Phillips Professional Corporation is a boutique law firm, specializing in plaintiff-side class actions.  The principals of the firm have helped victims in a wide range of cases, including product liability, consumer protection, aboriginal residential schools, franchise disputes and securities misrepresentations.

For more information on the Mefloquine Lawsuits, call our firm at 647- 261-4486, or email reception@waddellphillips.ca.

SOURCE Howie, Sacks & Henry LLP

Adult Congenital Heart Association Announces Funding of Organization’s Inaugural Research Grants

The six projects focus on important topics surrounding adult congenital heart disease.

MEDIA, Pa., May 1, 2019 – The Adult Congenital Heart Association (ACHA) has funded six research grants to advance the science of congenital heart disease (CHD) in adults. With the advent of this new ACHA program, the organization aims to improve the lives of CHD patients and future generations in partnership with medical professionals. 

“If it were not for medical research and innovation, adult congenital heart disease (ACHD) would not exist as a field,” says Jamil Aboulhosn, MD, FACC, FSCAI, ACHA Medical Advisory Board Chair, noting that in the textbooks of the early 20th century, there was barely a mention of CHD. “There are so many questions that are still unasked and unanswered in this field and it is imperative that we do our part to move things forward, and that can only happen through research and innovation.”

ACHA is the only nonprofit in the country dedicated solely to the unique needs of the 1.4 million adults born with heart defects, the most common birth defect in the United States, diagnosed in one in 100 births. These adults are living longer today with one of the many varying types of congenital heart defects that range among simple, moderate, and complex—which was not a reality 20 years ago.

“ACHA funding research grants is a watershed moment for our organization,” says ACHA President & CEO Mark Roeder. “A key goal of our Vision 2025 plan for the future was moving into direct research funding. We are thrilled that with the help of our Medical Advisory Board, we were able to move forward in this direction and to announce our six research grants. We look forward to momentum building in ACHA’s research program and awarding an increasing number of grants in the years ahead.”

The following two-year ACHD provider grants, jointly funded by ACHA and the Meil Family Foundation, were funded at $32,500 per year:

In addition, jointly funded by ACHA and Project Heart, the following three fellows received one-year grants of $10,000 each:

These first projects will start July 1, 2019, and ACHA is eager to report on progress and outcomes, as well as continue to fund grants annually after this inaugural round.

“The ACHA research program will provide reliable funding for ACHD investigator and trainee initiated studies,” says Arwa Saidi, MB, BCh, MEd, ACHA Medical Advisory Board Vice Chair. “These studies can produce the early data needed to design future large multi-center studies and subsequently guide and improve ACHD patient care.” 

About the Adult Congenital Heart Association 

The Adult Congenital Heart Association (ACHA) is a national not-for-profit organization dedicated to improving the quality of life and extending the lives of adults with congenital heart disease (CHD). ACHA serves and supports the more than 1.4 million adults with CHD, their families and the medical community—working with them to address the unmet needs of the long-term survivors of congenital heart defects through education, outreach, advocacy, and promotion of ACHD research. For more information about ACHA, contact (888) 921-ACHA or visit www.achaheart.org

HelloMD chosen as first telehealth provider for Medical Cannabis by Shoppers website

TORONTO, May 1, 2019 /CNW/ - HelloMD will now provide patients in Canada with convenient access to practitioner-led advice about medical cannabis through a new relationship with Shoppers Drug Mart's online medical cannabis platform.

Since its launch in 2015, HelloMD's turnkey telehealth platform has facilitated more than 100,000 virtual consults between medical cannabis patients and licensed practitioners. HelloMD is currently active in Canada and the United States.

The Medical Cannabis by Shoppers website now features a dedicated portal operated by HelloMD. Patients can access live video consultations with licensed healthcare practitioners through the dedicated portal seven days a week, from the comfort of their home. 

Following a consultation with a healthcare practitioner, patients that receive a medical document authorizing their registration as a medical cannabis patient may return to the Medical Cannabis by Shoppers website to register and begin choosing from its wide selection of approved products, or direct HelloMD to send their medical document to an alternative licensed producer.

"We are honoured that Shoppers Drug Mart has trusted us to provide discreet, expert guidance to their patients seeking online advice about medical cannabis," said Larry Lisser, senior vice-president of business development at HelloMD. "We are excited to be part of this innovation, and to help Canadian patients get more convenient access to information and treatment."

About HelloMD

HelloMD is the leading digital health care platform for medical cannabis, and has facilitated more than 100,000 virtual consults between cannabis patients and licensed practitioners. The company's white-label solutions enable third parties to quickly deploy a turnkey telehealth solution, complete with the technology, practitioners and support personnel required to improve patient onboarding processes.

SOURCE HelloMD

Ontario Nurses' Association Celebrates Historic Pay Equity Win

A 13-year pursuit for fairness and equity for nursing home Registered Nurses 

TORONTO, May 1, 2019 /CNW/ - The Ontario Nurses' Association (ONA) is celebrating a significant win following a 13-year-long battle to maintain pay equity rights for registered nurses (RNs) working in female-dominated professions.

A decision released late yesterday by Ontario's Divisional Court held that nurses working in private nursing homes without access to male comparators in their workplaces will now have the right to maintain pay equity with continuing reference to a male comparator.

"This case is a historic win for women's equality rights," says ONA President Vicki McKenna, RN. "The Court's ruling that the Pay Equity Act must be interpreted in a manner that is consistent with the values upheld by the Canadian Charter of Rights and Freedoms will ensure that RNs working in private nursing homes will have their pay equity rights maintained. 

The proxy sections of the Pay Equity Act provide a way for women in female-dominated, public-sector organizations to achieve pay equity where there are no male comparators in their workplace. Under the proxy method, public-sector organizations with no male job classes are able to access the job value and pay equity target pay rates from another public-sector organization that has already achieved pay equity in order to complete its own pay equity plan. Under the Act,the proxy employer for nursing homes is the municipal homes for the aged.

McKenna notes that in 1995, ONA and a central group of nursing homes entered into a pay equity plan that provided pay equity adjustments across the nursing home pay scale of varying amounts. By 2005, the pay for RNs worwking in the municipal homes for the aged had increased, creating a wage gap between RNs working in nursing homes and those working in municipal homes for the aged.

ONA, working with the Service Employees International Union (SEIU), had asked the Divisional Court to quash an earlier Pay Equity Hearings Tribunal decision and declare that the Pay Equity Act, properly interpreted, requires that pay equity maintenance in the proxy sector requires ongoing reference to male work. 

The Divisional Court has ordered the Tribunal to specify the procedures that should be used to ensure that claimants in the proxy sector have access to a male comparator, and to prevent further delays in the pay equity relief that they have sought for many years.

McKenna says that this has been a "marathon, 13-year pursuit of fairness and equity."

ONA is the union representing more than 65,000 registered nurses and health-care professionals, as well as 18,000 nursing student affiliates, providing care in hospitals, long-term care facilities, public health, the community, clinics and industry. 

Visit us at: www.ona.orgFacebook.com/OntarioNurseswww.Twitter.com/OntarioNurses

SOURCE Ontario Nurses' Association

ASTR0-DURANCE® BUNGEE SYSTEMS OPENS IN CANADA!

A cutting-edge bungee exercise concept that has revolutionized the way people look at fitness!
(Cape Coral, FL) April 18th, 2019 – In March 2019, Julia and John Hayes of Toronto, Ontario Canada officially obtained exclusive rights to distribute Astro-Durance Bungee Systems throughout Canada. Their new company’s name is ASTRO-DURANCE® CANADA, LTD.The Hayes plan to service the vast territory by developing a network of sub-distribution centers in key areas throughout Canada that will assist in distributing Astro-Durance Bungee Systems and related products to gyms, studios, fitness centers and the medical field. In addition, Astro-Durance Canada, LTD, is authorized to train and certify individuals for Astro-Durance Bungee Systems. Upcoming bungee training and certification classes will be listed on their website.
Astro-Durance® Bungee Systems is a new bungee fitness phenomenon that’s gaining popularity in the health and fitness industry. Astro-Durance® bungee exercise is changing the way the world views fitness because it allows the client to rev cardio in seconds, burn fat fast, build muscle strength, increase endurance, improve flexibility and balance for all ages from kids to people in their 90s. Astro-Durance motion-based bungee exercise accommodates all fitness levels, shapes and sizes, and those with physical limitations. Everyone can exercise and perform plyometrics with no added pressure on the joints, pain free and have lotsof fun doing it!
With Astro-Durance® Bungee motion-based exercise, the person is supported by bungees to provide the needed balance and flexibility they do not have on their own. They can exercise safely supported without stress on their joints because it is all motion-based. It’s like giving them wings to work out with. The body’s circulatory systems (blood and lymphatic) get revved up and moving like they are designed to do naturally. With the lymph moving, the body can enhance its ability to build the immune system and eliminate toxins more efficiently. The blood gets pumping throughout the body to oxygenate cells and flowing to the brain to build chemicals the body needs for brain function and cell growth. Physically fit persons can perform more efficiently, with increased sets and repetitions performed faster than before. Depending on the bungee workout, the entire body gets a stretch. Astro-Durance® is a great workout for athletes and for those who play professional sports. It can take a person to their next fitness level fast.
John and Julia Hayes bring a lot of business experience to the project. They successfully owned and operated international underground high voltage installation companies that specialized in lead cable splicing and installation. In addition, they owned and operated a (third generation) high voltage electrical supply company. Presently the Hayes’s own and operate a pesticide-free regulation nine-hole golf course north of Toronto. “This is our retirement project and challenges us to find innovative ways to enjoy the golfing experience without polluting and damaging the water table and environment,” stated Julia.
And now they are bringing Astro-Durance® to Canada “We have been enticed out of our much anticipated and comfortable senior lifestyle by Patty Cummings’s dream of fitness for all - regardless of age, mobility, injury or physical challenges. We have spent the past two months in Cape Coral as “snowbirds” and the ‘Astro Durance bungee systems’ enabled me to drop 20 lbs. But more importantly, it has successfully corrected a very bad limp caused by deteriorating arthritic hip. I no longer experience that sharp pain when I move or the ache that was my constant companion when I was stationary. I never dreamed I would experience the thrill of releasing endorphins, strengthening my body and stimulating my lymphatic system.And the added bonus- it’s fun!” – Julia Hayes
“We feel that although the baby boomers are aging, they are still interested in maintaining a healthy lifestyle. Traditional fitness programmes are hard on the body and intimidating. Astro-Durance® appealed to us because we have witnessed substantial improvements in clients who have suffered strokes, depression, cerebral palsy, obesity, neuropathy, brain bleeds, arthritic knees and hips, and back pain. Astro-Durance bungee training is equally appropriate for those fitness buffs who want the maximum benefit from a high intensity fun workout. The bungee system provides resistance which both reduces stress on the joints and a high cardio vascular exercise programme.”- John Hayes
Astro-Durance Canada, LTD, a strong asset: Patty Cummings, CEO and creator of Astro-Durance® says, “I am proud to have Astro-Durance® Bungee Systems represented by such accomplished and well-respected business people like Julia and John Hayes. The fact that their love for the product and what it does for health and fitness motivated them to come out from retirement to open an Astro-Durance Distribution Center says it all. I believe ASTRO-DURANCE® CANADA, LTD’s network will definitely provide us with the market penetration needed to reach our full sales potential in the region. We have considered many distribution partners and we are confident that John and Julia’s past experience in owning and operating a successful distribution company will strengthen our combined efforts to leverage our position in the North American health and fitness market.”
ASTRO-DURANCE® Bungee Systems allows people with physical limitations to get the exercise their doctors tell them they need. It is helping people of all ages who suffer from autoimmune disorders like Arthritis, Muscular Sclerosis, Cerebral Palsy, Parkinson’s Disease, Autism, and those recovering from sports injuries and surgical procedures such as hip and knee replacement. It is even helping people who are recovering from strokes. People who are overweight are able to exercise longer and finally burn fat that equals weight loss. Client feedback has all been positive. People have less pain and can-do movements theycould never physically do before starting a motion-based bungee exercise program.
Patty L. Cummings, Entrepreneur - CEO of Astro-Durance, LLC and owner of P2 Personal Training, is a Fitness Educator, Personal Trainer, Public Speaker, Inventor, and Creator of Astro-Durance Bungee Systems, the new motion-based bungee exercise training concept, and fitness program. She has been featured in USA Today; Fox 4; CBS; ABC; MS News Now; News-Press; Business Innovators Radio; Never Too Late for Fitness Radio; and is featured in the #1 bestseller – “Expert Profiles Volume 2”. Her book “Get Your Bungee On! – The Future of Fitness”, Hit #1 on Amazon. com’s Best Seller List. Ms. Cummings teachesone and two-day workshops for Astro-Durance Bungee Training Certification and How to Start Your Business Workshops.
The Company: Astro-Durance Bungee Systems is manufactured and assembled in Sorrento, Florida in the United States, with home offices at 324 Nicholas Parkway West, Suite F, Cape Coral, Florida. The company officially launched its business in August 2017 and services customers throughout the United States and internationally with a distribution center in the United Kingdom and now in Canada. Through this Canadian partnership, Astro-Durance, LTD, looks forward to strengthening its presence in the North American market.To find out more about Astro-Durance, visit their website at www.astrodurance.com; or their Facebook page at Astro-Durance Bungee Fitness https://www.facebook.com/AstroDurance/ ; or call: 1-239-574-4291
To find out more about Astro-Durance® Canada,LTD, visit their website www.astrodurancecanada.com or their Facebook page at Astrod-Durance Canada Bungee Fitness at https://www.facebook.com/astrodurance.canada/
Astro-Durance CANADA, LTD

A Record Breaking $1.5 million Raised Through the Scotiabank Charity Challenge at Banque Scotia 21k de Montréal 2019

Québec's Anne-Marie Comeau and Ontario's Tristan Woodfine take top placing in Montréal

MONTRÉAL, April 28, 2019 /CNW/ - Taking advantage of dry, brisk conditions, Québec's Anne-Marie Comeau (1:14:06)  in the women's class, and Ontario's Tristan Woodfine (1:05:27) in the men's category, had strong victories on Sunday at Parc Jean-Drapeau in Montréal, for the 17th edition of the Banque Scotia 21k de Montréal. 

At press time, the Scotiabank Charity Challenge had raised over $1.5 million – a record for Banque Scotia 21k de Montréal – in support of 80 charities in Québec and the number is expected to continue to grow as fundraising remains open for 30 days after the event. 

"At Scotiabank, investing in our communities has been a focus for over 185 years," says Geneviève Brouillard, Regional Senior Vice President, Québec and Eastern Ontario, at Scotiabank. "Through the Scotiabank Charity Challenge we aim to inspire individuals to fundraise in support of their favourite charities. We are thrilled that over 1.5million has been raised for charity this year. It's great to see that the Scotiabank Charity Challenge continues to be an important part of the weekend events, year after year. We know that the funds raised will have a huge impact in the communities where we live, work, and run."

A two-day event, the Banque Scotia 21k de Montréal featured fun times for all, with various distances to choose from, including, 1k Kids Run, 5k, 10k and 21k. Over 7,000 participants crossed the start lines for yet another sold out event this year! 

"We are quite excited with the combined effort from the runners and charities associated with the event, it resulted with another record-breaking weekend in terms of funds raised for the Scotiabank Charity Challenge," says Francois Lecot, Race Director, Banque Scotia 21k de Montréal. "Our event has become a weekend long celebration offering a distance for everyone with a 21k, 10k, 5k & Kids Run. Over 7000 runners showed up at one of our start lines, mixing up challenge, fun and performance. We are also proud of the turnout and performances from Canadian runners Anne-Marie Comeau and Tristan Woodfine." 

The Scotiabank Charity Challenge is a turnkey fundraising program that provides a simple way for runners in these races to support local causes that make a significant impact on Canadian communities. Participating charities keep 100 per cent of the proceeds raised, as Scotiabank pays for all transaction and credit card fees. Scotiabank offers the Scotiabank Charity Challenge at six sponsored marathon events across Canada including Montréal, Halifax, Ottawa, Calgary, Vancouver and Toronto.  

Scotiabank believes in helping young people reach their infinite potential, and many organizations who take part in the Scotiabank Charity Challenge have a direct impact on our local youth. Young people are our future leaders and it's crucial to provide them with the skills and resources they need to succeed.

Banque Scotia 21k de Montréal Results :

Half marathon, Men

  1. Tristan Woodfine, Cobden, 1:05:27 
  2. Réjean Chiasson, Toronto, 1:07:59 
  3. Pierre-Lou Billerot, Montréal, 1:08:10

Half marathon, Women

  1. Anne-Marie Comeau, St-Ferréol-les-Neiges, 1:14:06 
  2. Rachel Hannah, Guelph, 1:15:14 
  3. Sasha Gollish, Toronto, 1:17:43

10k, Men

  1. Nicholas Grudev, South Burlington, 32:23 
  2. Arnaud Francioni, Montréal, 33:06 
  3. Maurice Bélanger, Montréal, 35:55

10k, Women

  1. Arianne Raby, Montréal, 36:53 
  2. Annie Laperle, Candiac, 37:32 
  3. Céline Best, Shannon, 39:28

5k, Men

  1. Phil Parrot-Migas, London, 15:36 
  2. Graydon Snider, Montréal, 16:28 
  3. Dimitri Nivole, Montréal, 16:40

5k, Women

  1. Céline Marks, Montréal, 18:18 
  2. Joelle White, Montréal, 18:52 
  3. Laurence Gauthier, Montréal, 19:14

The Banque Scotia 21k de Montréal race weekend is a world-class sporting event that brings together runners from across the country, and beyond, on both recreational and elite levels. The event takes place in one of Montréal's most beautiful locations; Parc-Jean Drapeau.

For a complete list of 2019 charities participating in the Scotiabank Charity Challenge, please visit the Banque Scotia 21k de Montréal's website.

For more highlights and complete race results, please visit the results page

Twitter and Instagram Hashtag: #Scotia21kMTL, #InfinitePotential and #CourseScotia

About Scotiabank
At Scotiabank, we aim to support organizations that are committed to helping young people reach their infinite potential. Young people are our future leaders and Scotiabank's goal is to help ensure that they have the necessary skills and resources they need to support their success. Together with our employees, the Bank supports causes at a grassroots level. Recognized as a leader for our charitable donations and philanthropic activities, in 2018, Scotiabank contributed more than $80 million to help our communities around the world.

Scotiabank is Canada's international bank and a leading financial services provider in the Americas. We are dedicated to helping our more than 25 million customers become better off through a broad range of advice, products and services, including personal and commercial banking, wealth management and private banking, corporate and investment banking, and capital markets. With a team of more than 98,000 employees and assets of over $1 trillion (as at January 31, 2019), Scotiabank trades on the Toronto Stock Exchange (TSX: BNS) and New York Stock Exchange (NYSE: BNS). For more information, please visit www.scotiabank.com and follow us on Twitter @ScotiabankViews.

About Canada Running Series
Canada Running Series is the nation's premier running circuit with eight events: four in Toronto, two in Vancouver, one in Edmonton and one in Montréal. It annually attracts some 60,000 participants and raises more than $6 million for some 320 mostly local charities.

The Series includes the IAAF Gold Label Scotiabank Toronto Waterfront Marathon, and the Athletics Canada National Marathon Championships. Since 1999, CRS has gained international recognition for innovation and organization.

We are passionately committed to staging great experiences for runners of all levels from Canadian Olympians and International stars, to healthy lifestyle people and charity runners; and to making sport part of sustainable communities and the city-building process. Our mission is "building community through the sport of running". 

Join us : http://www.canadarunningseries.com   Instagram –  Twitter –  Facebook - @RunCRS 

SOURCE Scotiabank

“Prejuvenation” 6 Things Millennials Can Do to Maintain Their Youth

www.drmanishshah.com

Image

Many people in their 20’s are stressed out about high post college student loan debt requiring side hustles to pay it off. They’re noticing tired eyes and premature wrinkles as they turn to filters to optimize their social media photos. There is pressure to keep up with celebrities their age not to mention the countless millennial “social media influencers” who are setting the new standard for beauty and youth. Bottomline, millennials are stressed, and they don’t want to look it. Dr. Manish Shah, a Denver, Colorado Board-Certified Plastic Surgeon who specializes in facial plastic surgery urges the under 30 crowd not to overdo it with expensive treatments and procedures that can actually make them look older and put them further into debt.

Here is Dr. Shah’s of 6 things millennials can do to maintain their youth.

1. Use sunblock every day.

“The best way to make sure your face is protected from the sun is to use a daily moisturizer with SPF of no less than 30,” explains Dr. Shah. He also suggests applying creams to your neck and chest to postpone wrinkling and sagging in these areas. “The sun protection done daily in your 20’s will pay off greatly in your 40’s,” he says.

2. Get your Vitamin C.

“Vitamin C is a huge collagen booster and it also reduces pores and brightens skin, and these are the exact things women in their late 30’s and 40’s complain about most,” he reveals. Foods such as cantaloupe, mango, pineapples, oranges, grapefruits, and berries are all packed with this antioxidant which, when eaten regularly does wonders to sustain a youthful glow.

3. Ditch the fast food and eat more fish.

Those late night post partying fries and pizza are to be expected and at 25 are difficult to avoid. Perhaps your metabolism can handle it, for now. Offset these weekend indulgences by eating fish during the week. “Fish oil has fatty acids can erase early wrinkles you may notice. It prevents inflammation which can only make wrinkles more noticeable and deeper over time. Many millennials who are picky eaters and avoid seafood can get Omega-3’s via supplements but getting it directly from eating fish is best,” Dr. Shah suggests.

4. Quit smoking.

Nothing will age you quicker than smoking. “It is possible for a 25-year-old to look 8-5 years younger, within just 3 months after quitting smoking. This number increases after age 30. Women over age 40 who don’t smoke typically look up to a decade younger than their counterparts who still smoke,” says Dr. Shah. There are a gazillion reasons to quit smoking. Linking it to vanity is a pretty powerful motivator.

5. Decrease your sugar intake.

You really want to start getting mindful about your sugar intake in your 20’s for many different reasons. “Sugars and carbohydrates are a beauty killer because they are pro-inflammatory. Pasta, ketchup, candy, ice cream, and fruit juices are often dietary staples for those under 30. Any inflammation in the body will show up on the face in the form of adult acne, sagging and wrinkling not to mention sallow skin tone,” warns Dr. Shah.

6. Maintain your glow with facials and peels.

While many millennials are starting off with “Baby Botox” which can postpone wrinkling, Botox isn’t cheap. It also can be a “gateway” treatment which leads to lip injections and fillers that often have a reverse effect making younger women appear older, cautions Dr. Shah. “Lasers and peels have come very far, offer an excellent solution for sun damage, skin texture, pores, acne scarring and cell turnover to stimulate collagen growth.

Dr. Shah concludes that millennials who get into a good solid habit of taking care of themselves both inside and out, will create a lifestyle of longevity. “Millennials raised by mothers who may have had breast implants, Botox and lip injections may feel that getting things “done” is normal. This is exactly why I am always very honest when advising patients under 25 on procedures they’re considering.”

About Dr. Manish Shah

Plastic Surgeon Colorado | Dr. Manish Shah, M.D. | Denver https://drmanishshah.com/ 

Manish Shah, M.D., F.A.C.S. is board-certified by the American Board of Plastic Surgery and member of the American Society of Plastic Surgeons, the American Society of Aesthetic Plastic Surgery and the International Society of Aesthetic Plastic Surgery. After completing his formal plastic surgery training in Plastic and Reconstructive Surgery at the Univ. of Tennessee College of Medicine, he moved to New York City and was selected for the prestigious Aesthetic Surgery Fellowship at Manhattan Eye, Ear, and Throat Hospital. He underwent extensive, advanced training in aesthetic surgery of the face, breasts, and body at the hands of some of the most renowned cosmetic surgeons in the world. Dr. Shah is one of only a select few plastic surgeons in the country who have undergone formal post-graduate training in aesthetic surgery.

Dr. Shah’s specialties include revision facial aesthetic surgery, rhinoplasty (“nose reshaping”), and aesthetic surgery of the breast (breast augmentation, breast lift, breast reduction). He is, however, well-trained in all areas of aesthetic surgery. Dr. Shah’s aim is to obtain a natural appearing transformation that complements the real you!